Frequency and predictors of ventilator-associated pneumonia recurrence: a meta-analysis
- PMID: 18461027
- DOI: 10.1097/SHK.0b013e31816f1f7c
Frequency and predictors of ventilator-associated pneumonia recurrence: a meta-analysis
Abstract
Large clinical series focusing on the risk factors associated with recurrence after the onset of an initial episode of ventilator-associated pneumonia (VAP) produced inconsistent results. A meta-analysis would be helpful to shed light on the issue. Our objective was to estimate the frequency of VAP recurrence and to identify risk factors associated with it. PubMed, Scopus, Current Contents, and references of retrieved articles were searched without language restrictions. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using both the Mantel-Haenszel fixed-effect and the DerSimonian-Laird random effects models. The overall frequency of VAP recurrence in 969 patients of the seven eligible reports was 26.8%. Among the 20 evaluated risk factors, only acute lung injury/acute respiratory distress syndrome (OR, 1.76; 95% CI, 1.12-2.75) and shock (OR, 1.55; 95% CI, 1.01-2.41) at the day of diagnosis of the first VAP episode were found to be associated with VAP recurrence. There was also evidence, albeit inconsistent, that severity of illness at intensive care unit admission was associated with VAP recurrence. Recurrence involves almost one in four cases of VAP and is associated with acute lung injury/acute respiratory distress syndrome and shock, but not with first-episode causative pathogens. Recognition of these predictors may permit the timely implementation of measures to prevent recurrence of VAP.
Similar articles
-
Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.Crit Care Med. 2007 Jan;35(1):146-54. doi: 10.1097/01.CCM.0000249826.81273.E4. Crit Care Med. 2007. PMID: 17080004
-
Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis.Shock. 2010 Jun;33(6):590-601. doi: 10.1097/SHK.0b013e3181cc0418. Shock. 2010. PMID: 19953007
-
Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients.Anesth Analg. 2009 Nov;109(5):1584-90. doi: 10.1213/ANE.0b013e3181b6e9b6. Epub 2009 Aug 27. Anesth Analg. 2009. PMID: 19713267
-
The impact of ventilator-associated pneumonia on the Canadian health care system.J Crit Care. 2008 Mar;23(1):5-10. doi: 10.1016/j.jcrc.2007.11.012. J Crit Care. 2008. PMID: 18359415 Review.
-
Ventilator-associated pneumonia: Improving outcomes through guideline implementation.J Crit Care. 2008 Mar;23(1):118-25. doi: 10.1016/j.jcrc.2007.11.013. J Crit Care. 2008. PMID: 18359429 Review.
Cited by
-
A Predominant Cause of Recurrence of Ventilator-Associated Pneumonia in Patients with COVID-19 Are Relapses.J Clin Med. 2023 Sep 7;12(18):5821. doi: 10.3390/jcm12185821. J Clin Med. 2023. PMID: 37762761 Free PMC article.
-
Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial.BMJ Open. 2021 May 13;11(5):e050105. doi: 10.1136/bmjopen-2021-050105. BMJ Open. 2021. PMID: 33986070 Free PMC article.
-
Clinical epidemiology and outcomes of ventilator-associated pneumonia in critically ill adult patients: protocol for a large-scale systematic review and planned meta-analysis.Syst Rev. 2019 Jul 20;8(1):180. doi: 10.1186/s13643-019-1080-y. Syst Rev. 2019. PMID: 31325967 Free PMC article.
-
Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol.BMJ Open. 2019 Feb 19;9(2):e024561. doi: 10.1136/bmjopen-2018-024561. BMJ Open. 2019. PMID: 30782909 Free PMC article.
-
Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial.Crit Care. 2023 May 30;27(1):211. doi: 10.1186/s13054-023-04457-y. Crit Care. 2023. PMID: 37254209 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources